3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomach Neoplasms
14
Prostatic Neoplasms
13
Colorectal Neoplasms
13
Neoplasms
12
Pancreatic Neoplasms
10
Endometrial Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Lung Neoplasms
7
Colonic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Hepatocellular
6
Oropharyngeal Neoplasms
5
Multiple Myeloma
5
Mouth Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Sarcoma
4
Recurrence
4
Rectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Interventions
Iodine-131
14
trametinib
9
dabrafenib
9
Thyroidectomy
9
Surgical Procedures, Operative
9
lenvatinib
8
Thyroxine
8
Magnetic Resonance Spectroscopy
8
pembrolizumab
7
Paclitaxel
7
anlotinib
6
Thyrotropin Alfa
6
selpercatinib
5
Sorafenib
5
Saline Solution
5
Radiofrequency Ablation
5
Everolimus
5
pazopanib
4
Vemurafenib
4
Sunitinib
4
Radiotherapy
4
Nivolumab
4
Fluorodeoxyglucose F18
4
Dexmedetomidine
4
Cyclophosphamide
4
Biopsy, Fine-Needle
4
Biopsy
4
Bevacizumab
4
apatinib
3
Triiodothyronine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thyroid Neoplasms
×
Observation
×
Clear all
NCT07543887
2026-04-22
EECRTKI
University of Pisa
Completed
15 enrolled